326 related articles for article (PubMed ID: 25622249)
21. Fbxw7 contributes to tumor suppression by targeting multiple proteins for ubiquitin-dependent degradation.
Fujii Y; Yada M; Nishiyama M; Kamura T; Takahashi H; Tsunematsu R; Susaki E; Nakagawa T; Matsumoto A; Nakayama KI
Cancer Sci; 2006 Aug; 97(8):729-36. PubMed ID: 16863506
[TBL] [Abstract][Full Text] [Related]
22. Oncogenic mutations in the FBXW7 gene of adult T-cell leukemia patients.
Yeh CH; Bellon M; Pancewicz-Wojtkiewicz J; Nicot C
Proc Natl Acad Sci U S A; 2016 Jun; 113(24):6731-6. PubMed ID: 27247421
[TBL] [Abstract][Full Text] [Related]
23. MYC is a critical target of FBXW7.
Sato M; Rodriguez-Barrueco R; Yu J; Do C; Silva JM; Gautier J
Oncotarget; 2015 Feb; 6(5):3292-305. PubMed ID: 25669969
[TBL] [Abstract][Full Text] [Related]
24. [Expression of Fbxw7 and its correlation with cell proliferation in human hepatocellular carcinoma].
Zhou ZY; Tu KS; Zhang J; Zheng X; Gao J; Yao YM; Liu QG
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Dec; 28(12):1303-6. PubMed ID: 23232523
[TBL] [Abstract][Full Text] [Related]
25. Rictor regulates FBXW7-dependent c-Myc and cyclin E degradation in colorectal cancer cells.
Guo Z; Zhou Y; Evers BM; Wang Q
Biochem Biophys Res Commun; 2012 Feb; 418(2):426-32. PubMed ID: 22285861
[TBL] [Abstract][Full Text] [Related]
26. Guttiferone K impedes cell cycle re-entry of quiescent prostate cancer cells via stabilization of FBXW7 and subsequent c-MYC degradation.
Xi Z; Yao M; Li Y; Xie C; Holst J; Liu T; Cai S; Lao Y; Tan H; Xu HX; Dong Q
Cell Death Dis; 2016 Jun; 7(6):e2252. PubMed ID: 27253416
[TBL] [Abstract][Full Text] [Related]
27. [Expression of FBXW7 in esophageal squamous cell carcinoma and its clinical significance].
Yu H; Ling T; Shi R; Shu Q; Li Y; Tan Z
Zhonghua Zhong Liu Za Zhi; 2015 May; 37(5):347-51. PubMed ID: 26463024
[TBL] [Abstract][Full Text] [Related]
28. XB130 expression in human osteosarcoma: a clinical and experimental study.
Wang X; Wang R; Liu Z; Hao F; Huang H; Guo W
Int J Clin Exp Pathol; 2015; 8(3):2565-73. PubMed ID: 26045762
[TBL] [Abstract][Full Text] [Related]
29. Loss of CDC4/FBXW7 in gastric carcinoma.
Milne AN; Leguit R; Corver WE; Morsink FH; Polak M; de Leng WW; Carvalho R; Offerhaus GJ
Cell Oncol; 2010; 32(5-6):347-59. PubMed ID: 20448329
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of Long Non-Coding RNA NNT-AS1 Correlates with Tumor Progression and Poor Prognosis in Osteosarcoma.
Ye H; Lin J; Yao X; Li Y; Lin X; Lu H
Cell Physiol Biochem; 2018; 45(5):1904-1914. PubMed ID: 29518771
[TBL] [Abstract][Full Text] [Related]
31. FBXW7 expression affects the response to chemoradiotherapy and overall survival among patients with oral squamous cell carcinoma: A single-center retrospective study.
Arita H; Nagata M; Yoshida R; Matsuoka Y; Hirosue A; Kawahara K; Sakata J; Nakashima H; Kojima T; Toya R; Murakami R; Hiraki A; Shinohara M; Nakayama H
Tumour Biol; 2017 Oct; 39(10):1010428317731771. PubMed ID: 29072128
[TBL] [Abstract][Full Text] [Related]
32. Conditional inactivation of Fbxw7 impairs cell-cycle exit during T cell differentiation and results in lymphomatogenesis.
Onoyama I; Tsunematsu R; Matsumoto A; Kimura T; de Alborán IM; Nakayama K; Nakayama KI
J Exp Med; 2007 Nov; 204(12):2875-88. PubMed ID: 17984302
[TBL] [Abstract][Full Text] [Related]
33. Novel Role of FBXW7 Circular RNA in Repressing Glioma Tumorigenesis.
Yang Y; Gao X; Zhang M; Yan S; Sun C; Xiao F; Huang N; Yang X; Zhao K; Zhou H; Huang S; Xie B; Zhang N
J Natl Cancer Inst; 2018 Mar; 110(3):304-15. PubMed ID: 28903484
[TBL] [Abstract][Full Text] [Related]
34. miR-24 promotes the proliferation, migration and invasion in human tongue squamous cell carcinoma by targeting FBXW7.
Zhao J; Hu C; Chi J; Li J; Peng C; Yun X; Li D; Yu Y; Li Y; Gao M; Zheng X
Oncol Rep; 2016 Aug; 36(2):1143-9. PubMed ID: 27350307
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-223 functions as an oncogene in human gastric cancer by targeting FBXW7/hCdc4.
Li J; Guo Y; Liang X; Sun M; Wang G; De W; Wu W
J Cancer Res Clin Oncol; 2012 May; 138(5):763-74. PubMed ID: 22270966
[TBL] [Abstract][Full Text] [Related]
36. FAM83D promotes cell proliferation and motility by downregulating tumor suppressor gene FBXW7.
Wang Z; Liu Y; Zhang P; Zhang W; Wang W; Curr K; Wei G; Mao JH
Oncotarget; 2013 Dec; 4(12):2476-86. PubMed ID: 24344117
[TBL] [Abstract][Full Text] [Related]
37. miR-92a is upregulated in cervical cancer and promotes cell proliferation and invasion by targeting FBXW7.
Zhou C; Shen L; Mao L; Wang B; Li Y; Yu H
Biochem Biophys Res Commun; 2015 Feb; 458(1):63-9. PubMed ID: 25623537
[TBL] [Abstract][Full Text] [Related]
38. Role of Fbxw7 expression in hepatocellular carcinoma and adjacent non-tumor liver tissue.
Imura S; Tovuu LO; Utsunomiya T; Morine Y; Ikemoto T; Arakawa Y; Kanamoto M; Iwahashi S; Saito Y; Takasu C; Yamada S; Ishikawa D; Bando Y; Shimada M
J Gastroenterol Hepatol; 2014 Oct; 29(10):1822-9. PubMed ID: 24731221
[TBL] [Abstract][Full Text] [Related]
39. FBXW7 suppresses epithelial-mesenchymal transition, stemness and metastatic potential of cholangiocarcinoma cells.
Yang H; Lu X; Liu Z; Chen L; Xu Y; Wang Y; Wei G; Chen Y
Oncotarget; 2015 Mar; 6(8):6310-25. PubMed ID: 25749036
[TBL] [Abstract][Full Text] [Related]
40. Wnt/β-catenin signaling inhibits FBXW7 expression by upregulation of microRNA-770 in hepatocellular carcinoma.
Wu WJ; Shi J; Hu G; Yu X; Lu H; Yang ML; Liu B; Wu ZX
Tumour Biol; 2016 May; 37(5):6045-51. PubMed ID: 26602384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
